ATE457305T1 - Neue 3-phenylpropionsäurederivate zur behandlung von diabetes - Google Patents
Neue 3-phenylpropionsäurederivate zur behandlung von diabetesInfo
- Publication number
- ATE457305T1 ATE457305T1 AT05826447T AT05826447T ATE457305T1 AT E457305 T1 ATE457305 T1 AT E457305T1 AT 05826447 T AT05826447 T AT 05826447T AT 05826447 T AT05826447 T AT 05826447T AT E457305 T1 ATE457305 T1 AT E457305T1
- Authority
- AT
- Austria
- Prior art keywords
- alkyl
- acid derivatives
- phenylpropionic acid
- aryl
- new
- Prior art date
Links
- XMIIGOLPHOKFCH-UHFFFAOYSA-N 3-phenylpropionic acid Chemical class OC(=O)CCC1=CC=CC=C1 XMIIGOLPHOKFCH-UHFFFAOYSA-N 0.000 title abstract 2
- 206010012601 diabetes mellitus Diseases 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 102000000536 PPAR gamma Human genes 0.000 abstract 1
- 108010016731 PPAR gamma Proteins 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
- 239000003446 ligand Substances 0.000 abstract 1
- 125000000896 monocarboxylic acid group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 125000001424 substituent group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/70—Sulfur atoms
- C07D277/74—Sulfur atoms substituted by carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/52—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings condensed with carbocyclic rings or ring systems
- C07D263/54—Benzoxazoles; Hydrogenated benzoxazoles
- C07D263/58—Benzoxazoles; Hydrogenated benzoxazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
- C07D277/62—Benzothiazoles
- C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
- C07D277/82—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Biomedical Technology (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Psychiatry (AREA)
- Child & Adolescent Psychology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Pyridine Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL371841A PL371841A1 (pl) | 2004-12-20 | 2004-12-20 | Nowe związki pochodne kwasu 3-fenylopropionowego |
| PCT/EP2005/056839 WO2006067086A1 (en) | 2004-12-20 | 2005-12-16 | New 3-phenylpropionic acid derivatives for the treatment of diabetes |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE457305T1 true ATE457305T1 (de) | 2010-02-15 |
Family
ID=36118603
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT05826447T ATE457305T1 (de) | 2004-12-20 | 2005-12-16 | Neue 3-phenylpropionsäurederivate zur behandlung von diabetes |
Country Status (25)
| Country | Link |
|---|---|
| US (2) | US7312338B2 (de) |
| EP (1) | EP1833805B1 (de) |
| JP (1) | JP2008524166A (de) |
| KR (1) | KR100923199B1 (de) |
| CN (1) | CN101084203A (de) |
| AT (1) | ATE457305T1 (de) |
| AU (1) | AU2005318221B2 (de) |
| BR (1) | BRPI0519584A2 (de) |
| CA (1) | CA2588662C (de) |
| CY (1) | CY1110622T1 (de) |
| DE (1) | DE602005019327D1 (de) |
| DK (1) | DK1833805T3 (de) |
| ES (1) | ES2341020T3 (de) |
| HR (1) | HRP20100079T1 (de) |
| IL (1) | IL183563A0 (de) |
| MX (1) | MX2007007452A (de) |
| NO (1) | NO20073736L (de) |
| PL (2) | PL371841A1 (de) |
| PT (1) | PT1833805E (de) |
| RS (1) | RS51228B (de) |
| RU (1) | RU2360906C2 (de) |
| SI (1) | SI1833805T1 (de) |
| UA (1) | UA89807C2 (de) |
| WO (1) | WO2006067086A1 (de) |
| ZA (1) | ZA200704584B (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL371841A1 (pl) * | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
| PL372332A1 (pl) * | 2005-01-19 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| CN107417707A (zh) * | 2012-05-04 | 2017-12-01 | 萨穆梅德有限公司 | 1H‑吡唑并[3,4‑b]吡啶及其治疗应用 |
| KR20220138654A (ko) * | 2021-04-06 | 2022-10-13 | 주식회사 온코크로스 | 당뇨병의 예방 또는 치료용 화합물 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS58125039A (ja) | 1982-01-21 | 1983-07-25 | Konishiroku Photo Ind Co Ltd | 写真用２当量イエロ−カプラ− |
| US5296486A (en) * | 1991-09-24 | 1994-03-22 | Boehringer Ingelheim Pharmaceuticals, Inc. | Leukotriene biosynthesis inhibitors |
| PL174610B1 (pl) * | 1992-07-03 | 1998-08-31 | Smithkline Beecham Plc | Nowe związki heterocykliczne |
| JPH09505083A (ja) | 1994-03-12 | 1997-05-20 | ユーハン・コーポレーション | トリアゾール化合物およびその製造方法 |
| GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
| JP4618845B2 (ja) | 1999-06-09 | 2011-01-26 | 杏林製薬株式会社 | ヒトペルオキシゾーム増殖薬活性化受容体（ＰＰＡＲ）αアゴニストとしての置換フェニルプロピオン酸誘導体 |
| ATE260912T1 (de) | 1999-09-08 | 2004-03-15 | Glaxo Group Ltd | Oxazol ppar antagonisten |
| FR2808798A1 (fr) * | 2000-05-09 | 2001-11-16 | Hoechst Marion Roussel Inc | Nouveaux derives antagonistes du recepteur de la vitronectine |
| WO2003011814A1 (en) | 2001-07-30 | 2003-02-13 | Novo Nordisk A/S | Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| EP1414806A1 (de) | 2001-07-30 | 2004-05-06 | Novo Nordisk A/S | Neue vinyl-n-(2-benzoylphenyl)-l-tyrosinderivate und deren verwendung als antidiabetika usw. |
| JP4383177B2 (ja) * | 2002-03-01 | 2009-12-16 | スミスクライン ビーチャム コーポレーション | ｈＰＰＡＲ活性化剤 |
| US6653334B1 (en) * | 2002-12-27 | 2003-11-25 | Kowa Co., Ltd. | Benzoxazole compound and pharmaceutical composition containing the same |
| PL371841A1 (pl) * | 2004-12-20 | 2006-06-26 | ADAMED Sp.z o.o. | Nowe związki pochodne kwasu 3-fenylopropionowego |
| PL372332A1 (pl) * | 2005-01-19 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
| PL372356A1 (pl) * | 2005-01-20 | 2006-07-24 | ADAMED Sp.z o.o. | Nowe związki, pochodne kwasu 3-fenylopropionowego |
-
2004
- 2004-12-20 PL PL371841A patent/PL371841A1/pl not_active Application Discontinuation
-
2005
- 2005-12-08 US US11/298,920 patent/US7312338B2/en not_active Expired - Fee Related
- 2005-12-16 AU AU2005318221A patent/AU2005318221B2/en not_active Ceased
- 2005-12-16 SI SI200530974T patent/SI1833805T1/sl unknown
- 2005-12-16 BR BRPI0519584-5A patent/BRPI0519584A2/pt not_active IP Right Cessation
- 2005-12-16 DK DK05826447.4T patent/DK1833805T3/da active
- 2005-12-16 EP EP05826447A patent/EP1833805B1/de not_active Expired - Lifetime
- 2005-12-16 JP JP2007546072A patent/JP2008524166A/ja active Pending
- 2005-12-16 PT PT05826447T patent/PT1833805E/pt unknown
- 2005-12-16 RS RSP-2010/0117A patent/RS51228B/sr unknown
- 2005-12-16 UA UAA200708225A patent/UA89807C2/ru unknown
- 2005-12-16 MX MX2007007452A patent/MX2007007452A/es active IP Right Grant
- 2005-12-16 ES ES05826447T patent/ES2341020T3/es not_active Expired - Lifetime
- 2005-12-16 WO PCT/EP2005/056839 patent/WO2006067086A1/en not_active Ceased
- 2005-12-16 PL PL05826447T patent/PL1833805T3/pl unknown
- 2005-12-16 HR HR20100079T patent/HRP20100079T1/hr unknown
- 2005-12-16 RU RU2007127724/04A patent/RU2360906C2/ru not_active IP Right Cessation
- 2005-12-16 AT AT05826447T patent/ATE457305T1/de active
- 2005-12-16 CA CA2588662A patent/CA2588662C/en not_active Expired - Fee Related
- 2005-12-16 CN CNA200580043841XA patent/CN101084203A/zh active Pending
- 2005-12-16 KR KR1020077015791A patent/KR100923199B1/ko not_active Expired - Fee Related
- 2005-12-16 DE DE602005019327T patent/DE602005019327D1/de not_active Expired - Lifetime
-
2007
- 2007-04-26 US US11/740,820 patent/US7919515B2/en not_active Expired - Fee Related
- 2007-05-30 IL IL183563A patent/IL183563A0/en unknown
- 2007-06-04 ZA ZA200704584A patent/ZA200704584B/xx unknown
- 2007-07-18 NO NO20073736A patent/NO20073736L/no not_active Application Discontinuation
-
2010
- 2010-03-29 CY CY20101100293T patent/CY1110622T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2008524166A (ja) | 2008-07-10 |
| CY1110622T1 (el) | 2015-04-29 |
| US20070088061A1 (en) | 2007-04-19 |
| US7312338B2 (en) | 2007-12-25 |
| AU2005318221A1 (en) | 2006-06-29 |
| EP1833805B1 (de) | 2010-02-10 |
| NO20073736L (no) | 2007-07-18 |
| CN101084203A (zh) | 2007-12-05 |
| HRP20100079T1 (hr) | 2010-04-30 |
| RS51228B (sr) | 2010-12-31 |
| KR100923199B1 (ko) | 2009-10-22 |
| WO2006067086A1 (en) | 2006-06-29 |
| DE602005019327D1 (de) | 2010-03-25 |
| ES2341020T3 (es) | 2010-06-14 |
| PT1833805E (pt) | 2010-03-31 |
| UA89807C2 (ru) | 2010-03-10 |
| PL371841A1 (pl) | 2006-06-26 |
| KR20070097057A (ko) | 2007-10-02 |
| SI1833805T1 (sl) | 2010-05-31 |
| CA2588662A1 (en) | 2006-06-29 |
| RU2360906C2 (ru) | 2009-07-10 |
| IL183563A0 (en) | 2007-09-20 |
| ZA200704584B (en) | 2008-10-29 |
| US20070219259A1 (en) | 2007-09-20 |
| AU2005318221B2 (en) | 2009-09-17 |
| MX2007007452A (es) | 2007-11-07 |
| US7919515B2 (en) | 2011-04-05 |
| PL1833805T3 (pl) | 2010-04-30 |
| EP1833805A1 (de) | 2007-09-19 |
| CA2588662C (en) | 2010-12-07 |
| RU2007127724A (ru) | 2009-01-27 |
| BRPI0519584A2 (pt) | 2009-02-17 |
| DK1833805T3 (da) | 2010-05-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE366724T1 (de) | Kondensierte heterocyclische derivate | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| NO20090952L (no) | N-(aminoheteroaryl) - lh - indol-2-karboksamidderivater og fremstilling og terapeutisk anvendelse derav | |
| NO20074657L (no) | Nitrogenholdige aromatiske ringforbindelser | |
| SI1716152T1 (sl) | Kondenzirane heterociklične spojine in njihova uporaba kot antagonisti metabotropnega receptorja za zdravljenje gastrointestinalnih motenj | |
| NO20056007L (no) | Dobbel NK1/NK3 antagonister for behandling av schizofreni | |
| EA200501315A1 (ru) | 8-ЗАМЕЩЁННЫЕ ПРОИЗВОДНЫЕ 6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
| EA200501311A1 (ru) | ПРОИЗВОДНЫЕ ЗАМЕЩЁННОГО 8-ПЕРФТОРАЛКИЛ-6,7,8,9-ТЕТРАГИДРОПИРИМИДО[1,2-a]ПИРИМИДИН-4-ОНА | |
| MX2009004884A (es) | Derivados 8-piperidinil-2-piridinil-pirimido [1,2-a] pirimidin-6-ona y 8-piperidinil-2-pirimidinil-pirimido [1,2-a] pirimidin-6-ona sustuidos. | |
| CY1110622T1 (el) | Νεα παραγωγα 3-φαινυλοπροπιονικου οξεος για την αντιμετωπιση του διαβητη | |
| DE60221348D1 (de) | Substituierte chinoline zur behandlung von durch protozoen und retroviren verursachten co-infektionen | |
| CY1109678T1 (el) | Νεα παραγωγα 3-φαινυλπροπιονικου οξεος και χρηση αυτων ως συνδετηρες του υποδοχεα ppar-γαμμα | |
| NO20073330L (no) | Sulfanylsubstituerte fenylmetanoner som glycintransportor 1 (glyt-1) inhibitorer for behandling av nevrologiske og nevropsykiatriske forstyrrelser | |
| ATE374366T1 (de) | Aminophenoxyacetamid derivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DE502004006253D1 (de) | Substituierte benzoylureidopyridyl-piperidin- und -pyrrolidin-carbons urederivate, verfahren zu deren herstellung und deren v erwendung | |
| RU2007122499A (ru) | Новые производные пиридонкарбоновой кислоты или их соли | |
| DE60321700D1 (de) | Pyrazolderivate und deren verwendung als therapeutische mittel für durch hiv vermittelte krankheiten | |
| DE50008905D1 (de) | Polycyclische thiazol-2-yliden amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel | |
| TH80502A (de) |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1833805 Country of ref document: EP |